The WC-135 Constant Phoenix is a special-purpose aircraft derived from the Boeing C-135 Stratolifter and used by the United States Air Force. Its mission is to collect samples from the atmosphere for the purpose of detecting and identifying nuclear explosions.

NmVac4-A/C/Y/W-135 is the commercial name for a polysaccharide vaccine that protects against meningococcal meningitis caused by Neisseria meningitidis, specifically the serotypes A, C, Y, and W-135. This vaccine is part of a broader group of meningococcal vaccines.

Dec 5, 2024 · Prevention of meningococcal infection caused by N. meningitidis serogroups A, C, Y, and W-135 in adults, adolescents, children, and infants ≥2 months of age.

Sep 6, 2024 · MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135 in individuals 2 months through 55...

WC-135 Constant Phoenix Mission The WC-135W Constant Phoenix atmospheric collection aircraft supports national level consumers by collecting particulate and gaseous effluents and debris from accessible regions of the atmosphere in …

Find information on the properties and dimensions of the W36x135 shape.

This vaccine is used to help prevent certain serious, sometimes fatal, bacterial infections (meningitis, meningococcemia). This infection may cause severe problems (hearing loss,...

MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135 in individuals 2 months through 55 years of age. MENVEO does not prevent N. meningitidis serogroup B infections.

A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix(®) in subjects aged 11–17 years: an open, randomised, controlled trial.

Indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135 in individuals. 0.5 mL/dose IM. No prevention against N....